Friday, March 29, 2024
Home Tags Bio

Tag: bio

Deep Bio Welcomes Grant Carlson as Chief Commercial Officer –...

0
Seasoned Industry Expert Joins Deep Bio to Drive Commercial Growth and Expansion. Deep Bio appoints Grant Carlson as the company's Chief Commercial Officer.SEOUL,...

Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Cont…...

0
The drug is proving to be safe and well-tolerated Annovis Bio, Inc. ANVS, announces the positive safety review by the Data and Safety Monitoring...

Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member...

0
Massive Bio, a globally recognized leader in the oncology space, has proudly announced its appointment as a founding member of CancerX, a groundbreaking...

Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of...

0
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc BLTE ("Belite Bio" or the "Company"), a clinical stage biopharmaceutical drug...

BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq – BIO-…...

0
WALL, N.J., May 30, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. BKYI, an innovative provider of workforce and customer identity and...

Ductor and TotalEnergies form JV to develop, build and operate a...

0
ZUG, Switzerland, May 24, 2023 /PRNewswire/ -- Ductor, a leading circular biotechnology company within biogas and organic fertilizers, and TotalEnergies, the global multi-energy...

Cabaletta Bio Announces Pricing of Public Offering of Common Stock –...

0
PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. ("Cabaletta" or the "Company") CABA, a clinical-stage biotechnology company focused on...

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board...

0
Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of Eliot Forster, Ph.D. as Chairperson of the Board...

Astellas Enters Into Definitive Agreement to Acquire Iveric Bio – IVERIC...

0
-Companies to Create World-Class Ophthalmology Entity- -Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19,...

Astellas Enters Into Definitive Agreement to Acquire Iveric Bio – IVERIC...

0
-Companies to Create World-Class Ophthalmology Entity- -Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19,...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News